Matching-Adjusted Indirect Comparison (Maic) Of The Efficacy And Tolerability Of Apalutamide And Darolutamide For The Treatment Of Nonmetastatic Castration-Resistant Prostate Cancer (Nmcrpc)

Value in Health(2019)

引用 1|浏览3
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要